Home > Category > > Small Molecule Compound > DCZ0415

DCZ0415

Glpbio

Catalog No：GC39370-50mg CAS No.：2242470-43-3 MDLNo： Brand:Glpbio purity： 特性： Purpose:DCZ0415 是一种有效的 TRIP13 抑制剂，可损害非同源末端连接修复并抑制 NF-κB 活性。DCZ0415 在体外，体内以及在耐药性骨髓瘤患者衍生的原代细胞中诱导抗骨髓瘤活性。DMSO: 62.5 mg/mL (175.35 mM)

Share

Size	Availability	Price(USD)
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	DCZ0415
CAS	2242470-43-3
Formula	C₂₃H₂₀N₂O₂
MW	356.42
Storage condition	Store at -20°C

Related literature

Sorry, there is no relevant literature

Related

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

History

DCZ0415

(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

NA ≥98%,99%e.e.

GW274150 phosphate

GW274150 phosphate

(11bR)-4-Hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-4-Hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

791616-56-3 ≥98%,98%e.e.

(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

1258327-06-8 ≥98%,99%e.e.

(11bS)-2,6-Bis(4-chlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-Bis(4-chlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

NA ≥98%,99%e.e.

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

1258276-28-6 ≥98%,99%e.e.

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

1193697-61-8 ≥98%,99%e.e.

Nylidrin hydrochloride

Nylidrin hydrochloride

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

1585988-92-6 ≥98%,99%e.e.